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Abstract
The emergence of severe acute respiratory syndrome coronavirus 2 in December
2019, presumed from the city of Wuhan, Hubei province in China, and the sub-
sequent declaration of the disease as a pandemic by the World Health Organization
as coronavirus disease 2019 (COVID‐19) in March 2020, had a significant impact on
health care systems globally. Each country responded to this disease in different
ways, however this was done broadly by fortifying and prioritizing health care
provision as well as introducing social lockdown aiming to contain the infection and
minimizing the risk of transmission. In the United Kingdom, a lockdown was in-
troduced by the government on March 23, 2020 and all health care services were
focussed to challenge the impact of COVID‐19. To do so, the United Kingdom
National Health Service had to undergo widespread service reconfigurations and
the so‐called “Nightingale Hospitals” were created de novo to bolster bed provision,
and industries were asked to direct efforts to the production of ventilators. A
government‐led public health campaign was publicized under the slogan of: “Stay
home, Protect the NHS (National Health Service), Save lives.” The approach had a
significant impact on the delivery of all surgical services but particularly cardiac
surgery with its inherent critical care bed capacity. This paper describes the impact
on provision for elective and emergency cardiac surgery in the United Kingdom,
with a focus on aortovascular disease. We describe our aortovascular activity and
outcomes during the period of UK lockdown and present a patient survey of atti-
tudes to aortic surgery during COVID‐19 pandemic.
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1 | BACKGROUND TO COVID‐19 AND
EFFECTS ON SERVICES FOR CARDIAC
SURGERY IN THE UNITED KINGDOM
The severe acute respiratory syndrome coronavirus 2 first emerged
in the city of Wuhan, China, in December 2019 and it has since
spread rapidly across the globe, causing a disease named as cor-
onavirus disease 2019 (COVID‐19) in February 2020 and with the
World Health Organization declaring a pandemic in March 2020.1 As
of August 20th, 2020, there were more than 22.2 million confirmed
cases of COVID‐19 and over 795,000 deaths reported globally
(Figure 1) with the United Kingdom being 12th among countries in
term of confirmed cases (more than 326,000) and 5th in COVID‐19‐
related deaths (more than 41,000; Figure 2).2
Public Health England (PHE) published the very first report on
COVID‐19 on January 22, 2020. Just 1 day later, the Emergency
Department at Royal London Hospital swabbed its first potential
COVID‐19 patient.3 The declaration of this disease as a pandemic put
health care systems in the United Kingdom on alert and the govern-
ment introduced a national lockdown on March 23, 2020 in an
attempt to contain the disease and minimize the transmission risk to
others. A campaign was launched under the slogan of “Stay home,
Protect the NHS (National Health Service) and Save lives.” Although a
critical step to combat this highly contagious disease, it created a
significant burden on an otherwise freely accessible health care sys-
tem, the NHS. The NHS had to undergo a significant transformation
diverting resources to frontline health care services including ambu-
lance services, emergency departments, and allocation of intensive
care beds in preparation for the potential influx of COVID‐19 patients
and the requirement for ventilatory support (Figure 3). De novo fa-
cilities, the Nightingale Hospitals, were created throughout the nation
to increase capacity; private hospital capacity was purchased, in-
dustries were tasked with producing ventilators and academia with
producing treatments and vaccines. Effectively, all elective care was
stopped with services only maintained for emergencies.
Amongst the many specialties affected by the NHS service re-
configuration was cardiac surgery, given its ownership of a large
resource of ventilated beds normally required in elective practice.
Attempts were made in a number of regions to create centralized
cardiac surgical services to continue the provision of care to this
high‐risk cohort and avoid secondary deaths due to untreated car-
diovascular diseases.4 The Royal College of Surgeons (RCS), Society
of Cardiothoracic Surgery in UK and Ireland (SCTS), and the NHS
issued guidelines and regular updates on the practice of cardiac
surgery during this pandemic, introducing protocols and pathways
to minimize the risk of COVID‐19 to patients and staff without
affecting the quality of service and care to those needing cardiac
surgery.5–11
The network of centers that perform cardiac surgery in England
generally responded to the crisis according to government guidance
by reducing or, more frequently, halting elective operating, but with
a degree of independence. The exact timeline during which each
center wound down elective and urgent services varied according to
local circumstances and pressures. The processes by which each
center managed patient pathways were dependent on local ar-
rangements. In addition, England, Wales, Scotland, and Northern
Ireland, each with its own devolved government, responded differ-
ently. This paper focusses on the experience of Liverpool Heart and
Chest Hospital (LHCH) with changes to service provision for cardiac
surgery, focussing on aortovascular patients.
2 | RECOMMENDATIONS AND
GUIDELINES DURING COVID ‐19 IN
BRITAIN
On March 20, 2020, the RCS published its initial, brief guidance for
surgeons who were working during the COVID‐19 pandemic, em-
phasizing the safety of the working force as well as the maintenance
of emergency surgical workforce and capabilities.5 The detailed
guidance came into force on March 26th, 2020 outlining the scope of
patient selection and flow of surgical practice across the United
Kingdom. Since then, the guidelines have been updated four times,
lastly on June 5th, 2020.
F IGURE 1 World Health Organization statistics of coronavirus disease 2019 globally. Source: www.WHO.int (Accessed August 22nd, 2020)
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The initial guidance involved the cancellation of all elective op-
erating cases, with a focus on operating on urgent/emergency and
otherwise life‐saving procedures.6 Patients were categorized into
four levels according to their need for surgery:
• Priority level 1a Emergency—operation needed within 24 h.
• Priority level 1b Urgent—operation needed with 72 h.
• Priority level 2 Surgery that can be deferred for up to 4 weeks.
• Priority level 3 Surgery that can be delayed for up to 3 months.
• Priority level 4 Surgery that can be delayed for more than
3 months.
With the gradual decline in the cases of COVID‐19, the service
gradually resumed its activities, slowly reintroducing elective surgery
on a phased basis. Elective cases were prioritized as Red, Amber,
Green (RAG rating) with red been classified as “urgent elective.”
With a similar approach but at a more specialized level, the SCTS
introduced national guidelines on the performance of cardiac sur-
gery. As its initial response, the society introduced a clear cardi-
othoracic surgery escalation framework on March 16th and 18th,
2020; which outlined the routine practice of operating theaters,
clinics, and the running of a multidisciplinary team (MDT) meetings.7
It classified cardiothoracic patients in four areas, the obligatory
F IGURE 2 United Kingdom coronavirus disease 2019 status of confirmed cases and deaths. Source: www.gov.uk (Accessed August
22nd, 2020)
F IGURE 3 Status of patient admission to
hospital and requirement of mechanical
ventilation in coronavirus disease 2019
patients in the United Kingdom. Source: www.
gov.uk (Accessed August 22, 2020)
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in‐patients, which required surgical intervention, the alternative
(nonsurgical) pathways including inpatients and those to be managed
by ambulatory base services, the day‐cases, and finally, the out-
patients, whose hospital visits were to be kept at the minimum safe
level. The society also developed a clear pathway for patient selec-
tion during the initial lockdown and to smooth the gradual resump-
tion of elective activity. The guidelines not only included patient
selection but also focused on triage methods of such cohort,
COVID‐19 screening methods and tests, the use of personal pro-
tection equipment, and the management of operating theaters. These
guidelines were implemented nationwide and helped in containing
the spread of COVID‐19 in cardiac surgery patients.8 The society's
latest guideline on resumption of elective activity eliminates the
requirement for preoperative radiological screening if they have
been self‐isolating for 14 days before surgery, provided that they
have no COVID‐19‐related symptoms and have negative COVID‐19
nasopharyngeal swab within 72 h of surgery date.9
The NHS also issued several, nationwide guidelines to provide in-
sights on speciality practice during the COVID‐19 pandemic. Most of the
clinical guidelines and recommendations were interlinked with the work
of the RCS and SCTS. The NHS and PHE recognized that cardiothoracic
surgery, like any other speciality, needed service modification which
depended on the unit and the region of service, considering that some
cardiothoracic units are incorporated as part of large trauma centers
while others are tertiary units without emergency department service.10
The NHS categorized the patients into six major groups:
1. Obligatory in‐patients: Those patients who need immediate
admission and surgical intervention.
2. Alternative pathways: This is categorized into two subgroups:
a. In‐patient: The condition can reasonably be managed on an
ambulatory basis after a more limited in‐patient stay than
normal; for example, ambulatory chest drain management.
b. Ambulatory: The condition can reasonably be managed on an
ambulatory basis.
3. Day‐cases: Surgery can be safely undertaken for a large number
of conditions.
4. Surgery and interventional care that can be postponed.
5. Trauma surgery.
6. First contact and clinics.
In addition to the above, the work of the cardiothoracic team
was expanded to have a consultant‐led service, including patient
assessment, daily reviews, and decision‐making processes. The NHS
also advised to restructure training and education needs during this
time period to give priority to COVID‐19 patient care provision.12,13
In its latest guide, the NHS advised to utilize a remote consultation,
where appropriate. However, when face‐to‐face consultations were
needed, patients were brought in for further assessment in a con-
trolled and organized manner.11
PHE, NHS, SCTS, and RCS eventually merged their statements to
restructure the daily practice of cardiac surgery including modifica-
tion of hospital setups, patient selection, and screening process as
well as standards for intubation, operating, and provision of perio-
perative care for such patients. The joint statements were released in
accordance with the severity of the COVID‐19 pandemic within the
UK general population and the phase of the disease.
3 | SERVICE TRANSFORMATION
The NHS has been stretched to provide care for the already aging po-
pulation alongside the new cases of infected COVID‐19. As such and due
to limited capacity, there have been some attempts at the reconfigura-
tion of services, in some regions, by creating centralized units to provide
care for subspecialities that are not in direct response to COVID‐19. This
service modification entailed the creation of detailed and tailor‐made
protocols for planning cardiac surgery whilst optimizing the use of in-
tensive care and ward beds for the treatment of COVID‐19 cases. Such a
process required a nationwide assessment of capacity and capabilities to
accommodate such changes. In the North‐West of England, which serves
a population of 7.3 million, cardiac care was channeled through four
major cardiothoracic units: Blackpool, Manchester Royal, Manchester
Wythenshawe, and LHCH; LHCH was chosen to be the central unit for
cardiac and aortic surgery and led the development of the North‐West
Urgent Cardiothoracic Service (NUCS) Protocol to guide patient treat-
ment pathways (Appendix 1). As NUCS was set up, government mea-
sures took effect, reducing admissions; in reality, few patients were
channeled into Liverpool from other cardiac units, but some throughput
continued from our usual catchment area. North‐West regional pathways
still exist in preparation for a potential second spike. Similarly, in London
the service was reconfigured to operate in only two units among the
combined seven NHS centers serving the population of 8.5 million
people, forming the Pan London Emergency Cardiac Surgery (PLECS)
service.14 It is important to emphasize that the base of developing such
centralized services and the detailed protocol was to provide a COVID‐
19 free environment for patients undergoing cardiac surgeries. This is a
very critical point as COVID‐19 seems to have a significant correlation
with cardiovascular diseases and outcomes.15–17
Maintenance of a COVID‐19 free environment with clean pa-
tient pathways was key to maintaining a limited but safe service.
There was a significant reduction in the operational activities, as
high as 83% in some cardiac surgical units.4 Our center observed
similar reductions (Figure 4). Eventually, the establishment of
standardized patient pathways (Appendix 2) for perioperative care
and management in the theater (Appendix 3) aided in a gradual
increase in surgical activities. According to regional pathways
(NUCS and PLECS), patients were classified into four major
categories:
• Level 1: Elective patients who have indications for routine cardiac
surgery and would normally be added to an elective waiting list.
• Level 2: Urgent patients at home who are on the existing waiting
lists or in the process of referral but have critical/life‐threatening
anatomy with worsening symptoms or the need for urgent prog-
nostic intervention.
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• Level 3: Urgent patient undergoing interhospital transfers who by
definition are in hospital with prognostic/critical anatomy or
physiology or with unstable symptoms. They require cardiac sur-
gery within this hospital admission (but not on the same day), and
no other options for treatment are possible such as medical or
percutaneous intervention.
• Level 4: Emergency cases which are most commonly acute aortic
dissections, such patients have life‐threatening emergency aortic
and cardiac conditions and require surgery within hours.
For NUCS the decision‐making process started with the receipt
of an urgent inpatient referral, after triage at the referring regional
cardiac hospital (Blackpool and Manchester). These were directed to
our local COVID‐19 daily MDT along with our local urgent referrals.
All our 10 weekly MDTs were amalgamated into a single and virtual
COVID‐19 MDT with widespread attendance. After review of the
available information, an outcome was communicated to the refer-
ring clinical team and the patient. If the intervention was deemed
necessary, then procedural planning took place and the case was
allocated to a consultant and the date for surgery identified. Emer-
gency referrals were processed in the usual way by on‐call staff.
A number of patients requiring emergency care were referred to
Liverpool on the basis of the NUCS arrangement.
4 | AORTOVASCULAR DISEASE AND
COVID ‐19 AT LHCH
LHCH is one of the very few centers in the United Kingdom offering
medical and surgical services for patients with complex aortovas-
cular diseases. The hospital is the only stand‐alone Trust in the
United Kingdom offering only cardiovascular and thoracic services
and as such has no Emergency Department or Acute Medical Ad-
missions Facility. Four of fifteen cardiac surgeons specialize in aor-
tovascular surgery with a separate emergency on‐call rota. The team
also works with local vascular surgeons under the banner of
Liverpool Cardiovascular Surgery, with regular joint operating,
commonly on hybrid cases. From March 23, the independent elective
listing of patients for surgery by consultants was abandoned. General
cardiac activity was wound down, under the direction of the central
government, to free up critical care capacity for the potential
transfer of COVID‐19 patients from acute hospitals in the region.
The activity was reduced from five cardiac theaters and 10 cases per
day to four theaters and four cases per day, with only urgent patients
allocated from a common pool. Aortovascular patients, urgent and
emergency, had to compete with cardiac surgical patients for theater
space. All patients were discussed at the daily virtual “COVID‐19
MDT” where an emphasis was placed on directing patients towards
medical or minimally invasive therapy (endovascular) whenever
possible. With time, a number of high‐risk elective patients were
operated.
4.1 | Risk assessment of elective aortovascular
patients
A major issue in this period was the quantification of post-
operative COVID‐19 infection in “clean” patients, thus balancing
the additional risks of death from viral infection versus the risk of
a putative delay in surgery—a delay of at least 3 months was
presumed. For aortovascular disease, the Vascular Society of
Great Britain & Ireland (UK) offered guidance by increasing the
size threshold for elective intervention for the abdominal aortic
aneurysm to more than 7 cm18 as did the Society for Vascular
Surgery in the United States, recommending intervention only on
the symptomatic thoracoabdominal disease.19 The evidence base
underlying this advice was opaque at best. We “RAG rated” (Red,
Amber, Green) and chose to operate on the so‐called “Red urgent
elective” patients with COVID screening and “clean hospital
pathways.” The definition of red was a symptomatic severe dis-
ease. During this period, we made no adjustments to size‐based
guidelines.
F IGURE 4 Average weekly cardiac surgery
activities at Liverpool Heart and Chest
Hospital
HARKY ET AL. | 5
4.2 | Emergency aortovascular patients
There were unanimous recommendations from all advisory groups to
treat emergency life‐threatening disease as normal while adopting
appropriate safeguarding procedures for staff and other patients
within the hospital.
4.3 | Referral activity
A commonly observed phenomenon during this period was a dra-
matic reduction in both elective and urgent/emergency referrals
thought to be due to very few patients presenting to the hospital due
to a fear of COVID‐19 and local triage by referring doctors.
4.4 | Outcomes of operated aortovascular
patients
We examined our outcomes between the dates of March 1, 2020 and
July 4, 2020. A total of 59 patients were operated (Table 1) during this
period. In normal times we would expect the four aortovascular surgeons
to perform roughly one elective/urgent case each per week over
42 weeks/year (i.e., total 56 cases) plus emergencies, suggesting our
aortovascular activity was largely maintained during this 14‐week period.
(i) Elective (Red on RAG rated): During this period, we performed
operations on elective patients including root, arch, descending
thoracic aorta, and thoracoabdominal aortic aneurysm surgery
including thoracic endovascular aortic repair. One of these
elective patients turned COVID‐19 positive in the postoperative
period but did not develop COVID‐19 pneumonia; the COVID‐
19‐related mortality was zero.
(ii) Urgent: Urgent patients were those referred in from other hospi-
tals and in‐house patients requiring surgery during the same ad-
mission. Patients were screened for COVID‐19 at referring
hospitals and underwent computed tomography (CT) screening
and repeat COVID‐19 swabs, lactic dehydrogenase assay, and
lymphocyte measurements on transfer. We operated on 21 such
patients. None developed COVID‐19 but there were three deaths.
(iii) Emergency: Emergency patients came into our unit from refer-
ring hospitals and were taken to the theater immediately with
COVID‐19 status unknown. We operated on nine such patients,
two of whom developed COVID‐19 in the postoperative course
but not COVID‐19 pneumonia. There was one non‐COVID‐19‐
related death.
(iv) Medically managed patients: We managed 15 aortovascular pa-
tients without surgery either because it was not indicated or
because patients were unfit for the necessary surgical proce-
dure. Eight were type A dissections (moribund, 3; major stroke,
1; subacute, 1; or patient too frail/comorbid; 3). Five patients
had surgically relevant thoracoabdominal aortic dissection or
aneurysm but were too frail/comorbid; one was an
uncomplicated acute type B (COVID‐19 positive). One patient
had a root abscess that was COVID‐positive and died while
awaiting a negative swab before transfer.
No patient in this cohort died of postoperative COVID‐19 pneu-
monia. It should be noted that our critical care area is divided into four
distinct rooms, an arrangement that facilitated the isolation of
COVID‐19‐positive patients. During this period, we regularly admitted
ventilated patients from neighboring acute hospitals with community‐
acquired COVID‐19. In summary, we attempted to maintain our
aortovascular patients COVID‐19‐free via a combination of pre-
operative screening, strict theater procedures, and separate pathways
the “clean” and the COVID‐19 cohort (Appendces 1–3).
It should be noted that our preoperative screening protocols
changed as evidence presented itself. At the start of the lockdown
period, we performed routine CT scanning and bronchoalveolar lavage
(BAL) in theater or when a patient returned to intensive treatment unit.
During late June 2020, we eventually abandoned CT scanning and a
plain chest radiograph was used instead to identify individuals with
early or suspected COVID pneumonia. In addition, it became clear the
BAL was highly sensitive in the detection of viral RNA, but it was
unclear whether this was simply dead virus indicating previous ex-
posure or rather an active infection. Our experience showed that a
positive BAL was of no consequence for the clinical course of the pa-
tient but created major issues for bed capacity with a need for isolation.
For this reason and during late July, BAL was stopped in elective pa-
tients with a preoperatively negative COVID‐19 swab, normal chest
X‐ray, and blood tests who had been isolating for 2 weeks.
We are thus only aware of one patient who should have un-
dergone urgent surgery for a root abscess but died following delays
while awaiting his status to change from COVID‐19 positive to ne-
gative. To our knowledge, no patients came to harm while on our
waiting lists for delayed elective surgery. We see this as validation of
the systems we developed to balance the need to make our critical
care beds available for the national COVID‐19 pandemic and the
needs of our patients with life‐threatening cardiovascular disease.
After this period, we gradually returned to normal work pat-
terns, with surgeons planning their operating lists independently,
progressively increasing elective activity as hospital pathways al-
lowed. We still use a RAG rating system at present.
5 | PATIENT PERSPECTIVE
To better understand the beliefs and attitudes of patients with aortic
pathology during COVID‐19, we conducted a survey through Aortic
Dissection Awareness UK and Ireland (ADA UKI).
A structured questionnaire was developed and preoperative
patients who are members of ADA UKI were invited to complete it
from August 17 and 25, 2020. A total of 29 responses were received
and the results are presented in Table 2.
Among the 29 patients, only one of them considered himself as
“awaiting surgery” while the rest 28 patients considered themselves
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TABLE 1 Perioperative characteristics
of patients that underwent aortovascular
intervention at Liverpool Heart and Chest
Hospital between March 1, 2020 and July
3, 2020
Variable Total (n = 59)
Elective
(n = 29) Urgent (n = 21)
Emergency
(n = 9)
Preoperative
Mean age (SD) 61.3 ± 14 65.0 ± 13.9 59.4 ± 13.9 53.4 ± 11.5
Male (%) 39 (66) 15 (52) 18 (86) 6 (67)
HTN (%) 36 (61) 20 (69) 11 (52) 5 (56)
Diabetes mellitus (%) 4 (7) 3 (10) 1 (5) 0 (0)
COPD (%) 7 (12) 4 (14) 3 (14) 0 (0)
Creatinine (SD) 81 ± 24 73 ± 21 82 ± 22 101 ± 37
PVD (%) 2 (3) 1 (3) 1 (5) 0 (0)
NYHA class III–IV (%) 30 (51) 11 (38) 15 (71) 4 (44)
Previous cardiac
surgery (%)
7 (12) 3 (10) 4 (19) 0 (0)
Previous aortic surgery (%) 13 (22) 6 (20) 6 (29) 1 (11)
Previous endovascular
intervention (%)
1 (2) 1 (3) 0 (0) 0 (0)
BAV (%) 10 (17) 3 (10) 5 (24) 2 (22)
Marfan (%) 5 (9) 3 (10) 2 (10) 0 (0)
COVID‐19 status
Preoperative
Negative (%) 44 (75) 20 (69) 18 (86) 6 (67)
Positive (%) 0 (0) 0 (0) 0 (0) 0 (0)
Unknown (%) 15 (25) 9 (31) 3 (14) 3 (33)
LDH (SD) 201 ± 73 181 ± 41 229 ± 12 na
Lymphocyte count (SD) 1.22 ± 0.51 1.21 ± 0.38 1.29 ± 0.61 1.31 ± 0.50
CT thorax (%) 36 (66) 19 (66) 16 (76) 2 (20)
Postoperative
Negative (%) 56 (95) 28 (97) 21 (100) 7 (78)
Positive (%) 3 (5) 1 (3) 0 (0) 2 (22)
COVID pneumonia (%) 0 (0) 0 (0) 0 (0) 0 (0)
COVID‐related
death (%)
0 (0) 0 (0) 0 (0) 0 (0)
Non‐COVID‐related
death (%)
4 (6) 0 (0) 3 (14) 1 (11)
Pathology
Aneurysm (%) 39 (66) 25 (86) 13 (62) 1 (11)
Aortic dissection (%) 12 (21) 4 (14) 2 (10) 6 (67)
IMH (%) 2 (3) 0 (0) 0 (0) 2 (22)
Others (%) 6 (10) 0 (0) 6 (28) 0 (0)
Operative
Isolated root (%) 19 (31) 6 (20) 7 (33) 6 (67)
Hemi arch (%) 11 (18) 3 (10) 3 (14) 5 (56)
Total arch (%) 4 (6) 2 (7) 0 (0) 2 (22)
FET (%) 4 (6) 2 (7) 0 (0) 2 (22)
DTA (%) 10 (16) 7 (24) 3 (14) 0 (0)
TAAA (%) 10 (16) 6 (20) 4 (19) 0 (0)
TEVAR (%) 5 (8) 3 (14) 1 (5) 1 (10)
Postoperative
Mechanical ventilation
time (h,SD)
27 ± 33 25 ± 33 23 ± 30 44 ± 33
Length of ICU stay
(h, SD)
126 ± 125 113 ± 132 111 ± 100 155 ± 125
(Continues)
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as “under surveillance” although they have been offered the option
of surgical intervention at the time of first assessment and rather
awaiting a confirmed date for surgery which has been significantly
affected by COVID‐19 pandemic.
More than 80% of them were more concerned about the delayed
aortic surgery than the possibility of contracting COVID‐19 in‐
hospital; over 70% of them had no concerns in attending hospital and
trusted their respective unit to have strict measures in place to
prevent cross‐infection. They would have preferred to have surgery
without delay despite the potential risk of COVID‐19 (72%). Fur-
thermore, most would have preferred a face‐to‐face follow‐up (59%)
while a clear majority did not feel that a routine follow‐up scan
should be delayed pending vaccine development (90%).
Our survey shows that, despite the potential risk of COVID‐19,
patients are more worried about their health from the underlying
aortic pathology than the possibility of contracting COVID‐19. As
this was a simple cross‐sectional survey on a small sample, results
should be interpreted carefully; larger qualitative studies are needed
to understand the impact of the COVID‐19 pandemic and its asso-
ciated delays over patients who are yet to have aortovascular
surgery.
6 | OUTPATIENTS
To minimize the risk of transmission of COVID‐19 to our patients and
health care professionals, all elective face‐to‐face out‐patient reviews
were canceled and turned into a virtual consultation by telephone or
video‐link. During this COVID‐19 pandemic, telemedicine has been
explored and utilized in many other specialities and it has proven its
value in such prospect.20–22 With the passage of the peak of COVID‐
19, “face to face” consultations were re‐established for a proportion of
patients, with all necessary preventative measures.
7 | RESTARTING SERVICES
Pathways and standard operating procedures have evolved through
multiple iterations in an attempt to return to normal pre‐COVID
activity levels while maintaining patient and staff safety. With the
advent of effective separation of preoperative and postoperative
patients, rapid COVID swabbing, radiological screening, and pre-
operative patient shielding, we have approached 80% theater oper-
ating capacity. Staff safeguarding is maintained through mandatory
social distancing, virtual MDTs, face masks as well as track and trace
methods. Today, most of the cardiac surgery centers across the UK
have resumed their activity in a phased return, initially with urgent/
emergency cases. Now, elective cases are considered for surgery on
the basis of RCS guidelines and patient self‐isolation for 14 days
before admission.
8 | THE NEW NORMAL AND SUMMARY
Without a doubt, the COVID‐19 pandemic has caused significant
disruption to services globally. One of the most affected sectors was
health care provision, which required extensive support from gov-
ernments and volunteers in order for it to provide safe care. Globally
there has been service reconfiguration, with some units shutting down
some of their services to cope with COVID‐19 patient influx while
Variable Total (n = 59)
Elective
(n = 29) Urgent (n = 21)
Emergency
(n = 9)
Tracheostomy (%) 3 (5) 1 (3) 1 (5) 1 (10)
Reoperation for
bleeding (%)
8 (13) 5 (17) 2 (10) 1 (10)
Mesenteric ischemia (%) 1 (2) 0 (0) 1 (5) 0 (0)
Stroke (%) 6 (10) 3 (10) 2 (10) 1 (10)
Paraplegia (%) 2 (3) 1 (3) 1 (5) 0 (0)
Renal replacement
therapy (%)
5 (8) 3 (10) 2 (10) 0 (0)
Acute MI (%) 0 (0) 0 (0) 0 (0) 0 (0)
30‐Day mortality
postopen repair (%)
2 (3) 0 (0) 2 (10) 0 (0)
30‐Day mortality post‐
TEVAR (%)
2 (3) 0 (0) 1 (5) 1 (10)
Abbreviations: BAV, bicuspid aortic valve; COPD, chronic obstructive pulmonary disease; COVID‐19,
coronavirus disease 2019; CT, computed tomography; DTA, descending thoracic aorta; FET, frozen
elephant trunk; HTN, hypertension; ICU, intensive care unit; IMH, intramural hematoma; LDH, lactate
dehydrogenase; MI, myocardial infarction; NYHA, New‐York Heart Association; PVD, peripheral
vascular disease; TAAA, thoracoabdominal aortic aneurysm; TEVAR, thoracic endovascular aortic
repair.
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others diverted their activity into a more centralized, regional hub to
be able to deliver emergency, specialist services. NHS England has
been in the frontline combating COVID‐19 and cardiothoracic surgical
services have been modified to reflect this. In England, the only re-
gions with a clear cardiothoracic surgical pathway for the COVID‐19
pandemic were London through PLEC and the North‐West of England.
Following service modifications, there remain thousands of pa-
tients affected by the cancellation of their operation, clinic assess-
ment, or follow‐up. The outcomes of this cohort are unknown; it will
be of great interest to understand how these patients, and their
quality of life, have been affected.
There is uncertainty about when a full cardiothoracic service will
re‐run and whether preoperative testing for COVID‐19 will be a
permanent requirement; data are emerging on a daily base and
to‐date there are more than 47,000 entries in PubMed. gov related
to COVID‐19, increasing on a daily base. Will the present state of
affairs be the new norm for cardiac surgeons for the foreseeable
future? How will the NHS provide its services in the future? Time and
further research will address these questions.
9 | CONCLUSIONS
The COVID‐19 pandemic has had a significant impact on our nation
causing death, disability, and resulting in incalculable effects on fa-
milies and social structures through long‐lasting consequences for
our economy. Through changes in social behavior, the building of our
bed base, and changes in NHS structures and priorities, the country
stopped the pandemic overwhelming our critical care capacity. There
was, however, a significant impact on NHS health care provision
including cardiac surgery. The burden of cardiovascular disease on
morbidity and mortality, as a consequence of these arrangements,
remains unknown at present. Our patient survey showed that
patients are more worried about risks to their health from underlying
aortic pathology than contracting COVID‐19 in hospital and its
associated perioperative risks. Cardiac surgeons have learned an
enormous amount on how to manage the service in the context of a
national pandemic. Hopefully, this manuscript will offer some insight
on how we managed the challenge.
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